ALB and lung carcinoma: The ALI, a composite index that integrates measures of inflammation and nutrition, including BMI, serum albumin, and the neutrophil-to-lymphocyte ratio (NLR), was initially used to assess the mortality risk in lung cancer patients (44, 45).